BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 11166921)

  • 1. Genomic structure and loss of heterozygosity of EPHB2 in colorectal cancer.
    Oba SM; Wang YJ; Song JP; Li ZY; Kobayashi K; Tsugane S; Hamada GS; Tanaka M; Sugimura H
    Cancer Lett; 2001 Mar; 164(1):97-104. PubMed ID: 11166921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Status of the DPC4 tumor suppressor gene in sporadic colon adenocarcinoma of Croatian patients: identification of a novel somatic mutation.
    Popović Hadzija M; Radosevic S; Kovacević D; Lukac J; Hadzija M; Spaventi R; Pavelić K; Kapitanović S
    Mutat Res; 2004 Apr; 548(1-2):61-73. PubMed ID: 15063137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inactivation of both alleles of the DPC4/SMAD4 gene in advanced colorectal cancers: identification of seven novel somatic mutations in tumors from Japanese patients.
    Koyama M; Ito M; Nagai H; Emi M; Moriyama Y
    Mutat Res; 1999 Aug; 406(2-4):71-7. PubMed ID: 10479724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High EPHB2 mutation rate in gastric but not endometrial tumors with microsatellite instability.
    Davalos V; Dopeso H; Velho S; Ferreira AM; Cirnes L; Díaz-Chico N; Bilbao C; Ramírez R; Rodríguez G; Falcón O; León L; Niessen RC; Keller G; Dallenbach-Hellweg G; Espín E; Armengol M; Plaja A; Perucho M; Imai K; Yamamoto H; Gebert JF; Díaz-Chico JC; Hofstra RM; Woerner SM; Seruca R; Schwartz S; Arango D
    Oncogene; 2007 Jan; 26(2):308-11. PubMed ID: 16819508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymerase chain reaction-based approaches for detection of allelic loss in the p53 tumor suppressor gene in colon neoplasms.
    Yamaguchi K; Sugano K; Fukayama N; Nakashima Y; Saotome K; Yokoyama T; Yokota T; Ohkura H
    Am J Gastroenterol; 1997 Feb; 92(2):307-12. PubMed ID: 9040212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomic structure of the human tetratricopeptide repeat-containing gene, TTC4, from chromosome region 1p31 and mutation analysis in breast cancers.
    Su G; Casey G; Cowell JK
    Int J Mol Med; 2000 Feb; 5(2):197-200. PubMed ID: 10639601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic alterations and oxidative metabolism in sporadic colorectal tumors from a Spanish community.
    Oliva MR; Ripoll F; Muñiz P; Iradi A; Trullenque R; Valls V; Drehmer E; Sáez GT
    Mol Carcinog; 1997 Apr; 18(4):232-43. PubMed ID: 9142218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple endocrine neoplasia type 1 (MEN1): LOH studies in a affected family and in sporadic cases.
    Valdes N; Alvarez V; Diaz-Cadorniga F; Aller J; Villazon F; Garcia I; Herrero A; Coto E
    Anticancer Res; 1998; 18(4A):2685-9. PubMed ID: 9703929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allele-specific loss of heterozygosity at the DAL-1/4.1B (EPB41L3) tumor-suppressor gene locus in the absence of mutation.
    Kittiniyom K; Mastronardi M; Roemer M; Wells WA; Greenberg ER; Titus-Ernstoff L; Newsham IF
    Genes Chromosomes Cancer; 2004 Jul; 40(3):190-203. PubMed ID: 15138999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of the multiple tumor suppressor genes and 12-lipoxygenase in human prostate cancer. Therapeutic implications.
    Gao X; Porter AT; Honn KV
    Adv Exp Med Biol; 1997; 407():41-53. PubMed ID: 9321930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of inactivation of the receptor tyrosine kinase EPHB2 in colorectal tumors.
    Alazzouzi H; Davalos V; Kokko A; Domingo E; Woerner SM; Wilson AJ; Konrad L; Laiho P; Espín E; Armengol M; Imai K; Yamamoto H; Mariadason JM; Gebert JF; Aaltonen LA; Schwartz S; Arango D
    Cancer Res; 2005 Nov; 65(22):10170-3. PubMed ID: 16288001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allelic loss of chromosome 17p, mutation of the p53 gene, and microsatellite instability in right- and left-sided colorectal cancer.
    Watatani M; Yoshida T; Kuroda K; Ieda S; Yasutomi M
    Cancer; 1996 Apr; 77(8 Suppl):1688-93. PubMed ID: 8608563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutational analysis of the p73 gene localized at chromosome 1p36.3 in colorectal carcinomas.
    Sunahara M; Ichimiya S; Nimura Y; Takada N; Sakiyama S; Sato Y; Todo S; Adachi W; Amano J; Nakagawara A
    Int J Oncol; 1998 Aug; 13(2):319-23. PubMed ID: 9664127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Definition of three minimal deleted regions by comprehensive allelotyping and mutational screening of FHIT,p16(INK4A), and p19(ARF) genes in nasopharyngeal carcinoma.
    Ko JY; Lee TC; Hsiao CF; Lin GL; Yen SH; Chen KY; Hsiung CA; Chen PJ; Hsu MM; Jou YS
    Cancer; 2002 Apr; 94(7):1987-96. PubMed ID: 11932901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
    Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
    Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of TGF-beta type I receptor for mutations and polymorphisms in head and neck cancers.
    Knobloch TJ; Lynch MA; Song H; DeGroff VL; Casto BC; Adams EM; Alam KY; Lang JC; Schuller DE; Weghorst CM
    Mutat Res; 2001 Aug; 479(1-2):131-9. PubMed ID: 11470488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allelic loss at 10q26 in osteosarcoma in the region of the BUB3 and FGFR2 genes.
    Mendoza S; David H; Gaylord GM; Miller CW
    Cancer Genet Cytogenet; 2005 Apr; 158(2):142-7. PubMed ID: 15796961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Homozygous deletion and frequent allelic loss of the 21q11.1-q21.1 region including the ANA gene in human lung carcinoma.
    Kohno T; Kawanishi M; Matsuda S; Ichikawa H; Takada M; Ohki M; Yamamoto T; Yokota J
    Genes Chromosomes Cancer; 1998 Mar; 21(3):236-43. PubMed ID: 9523199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Germline EPHB2 receptor variants in familial colorectal cancer.
    Zogopoulos G; Jorgensen C; Bacani J; Montpetit A; Lepage P; Ferretti V; Chad L; Selvarajah S; Zanke B; Hudson TJ; Pawson T; Gallinger S
    PLoS One; 2008 Aug; 3(8):e2885. PubMed ID: 18682749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new polymorphic site in intron 2 of TP53 characterizes LOH in human tumors by PCR-SSCP.
    Oliva MR; Saez GT; Latres E; Cordon-Cardo C
    Diagn Mol Pathol; 1995 Mar; 4(1):54-8. PubMed ID: 7735557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.